Making Lung Cancer Clinical Trials More Inclusive: Recommendations for Expanding Eligibility Criteria

被引:12
|
作者
Bonomi, Philip [1 ]
Blumenthal, Gideon [2 ]
Ferris, Andrea Stern [3 ]
Stewart, David J. [4 ]
Selig, Wendy K. D. [5 ]
Krug, Lee M. [6 ]
Allen, Jeff [7 ]
Ison, Gwynn [2 ]
Langer, Corey J. [8 ]
Melemed, Allen [9 ]
Odogwu, Lauretta [2 ]
Roy, Upal Basu [3 ]
Sandler, Alan [10 ]
机构
[1] Rush Presbyterian St Lukes Med Ctr, Chicago, IL USA
[2] US FDA, Silver Spring, MD USA
[3] LUNGev Fdn, Bethesda, MD USA
[4] Univ Ottawa, Ottawa, ON, Canada
[5] WSCollaborative, Mclean, VA USA
[6] Bristol Myers Squibb, Princeton, NJ USA
[7] Friends Canc Res, Washington, DC USA
[8] Univ Penn, Philadelphia, PA 19104 USA
[9] Eli Lilly, Indianapolis, IN USA
[10] Genentech Inc, San Francisco, CA USA
关键词
ONCOLOGY;
D O I
10.1016/j.jtho.2018.02.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:748 / 751
页数:4
相关论文
共 50 条
  • [21] Eligibility criteria in haematological cancer clinical trials-what's needed?
    Calissano, Mattia
    Panico, Maria Beatrice
    O'Connor, Daniel J.
    LANCET HAEMATOLOGY, 2020, 7 (01): : E10 - E10
  • [22] Eligibility criteria perpetuate disparities in enrollment and participation in pancreatic cancer clinical trials
    Riner, Andrea N.
    Girma, Selamawit
    Skoro, Nevena
    Gal, Tamas S.
    Herremans, Kelly M.
    Mukhopadhyay, Nitai
    Vudatha, Vignesh
    Raman, Shreya
    George, Thomas
    Trevino, Jose G.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (01)
  • [23] Eligibility Criteria in Advanced Urothelial Cancer Clinical Trials: An Assessment of Modernization and Inclusion
    Mercier, Benjamin D.
    Govindarajan, Ameish
    Castro, Daniela V.
    Li, Xiaochen
    Philip, Errol J.
    Feng, Matthew I.
    Prajapati, Sweta R.
    Chan, Elyse H.
    Lee, Kyle O.
    Sehgal, Ishaan
    Patel, Jalen
    O'Dell, Anna
    Chehrazi-Raffle, Alexander
    Ebrahimi, Hedyeh
    Rock, Adam
    Zengin, Zeynep Busra
    Meza, Luis A.
    Dizman, Nazli
    Hsu, Joann
    Liu, Sandy
    Dorff, Tanya B.
    Pal, Sumanta K.
    Tripathi, Abhishek
    CANCER MEDICINE, 2025, 14 (07):
  • [24] Comparison of Eligibility Criteria Between Protocols, Registries, and Publications of Cancer Clinical Trials
    Zhang, Sheng
    Liang, Fei
    Li, Wenfeng
    Tannock, Ian
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2016, 108 (11):
  • [25] A novel semantic representation for eligibility criteria in clinical trials
    Chondrogiannis, Efthymios
    Andronikou, Vassiliki
    Tagaris, Anastasios
    Karanastasis, Efstathios
    Varvarigou, Theodora
    Tsuji, Masatsugu
    JOURNAL OF BIOMEDICAL INFORMATICS, 2017, 69 : 10 - 23
  • [26] Textual inference for eligibility criteria resolution in clinical trials
    Shivade, Chaitanya
    Hebert, Courtney
    Lopetegui, Marcelo
    de Marneffe, Marie-Catherine
    Fosler-Lussier, Eric
    Lai, Albert M.
    JOURNAL OF BIOMEDICAL INFORMATICS, 2015, 58 : S211 - S218
  • [27] Do eligibility criteria restrict access to clinical trials?
    Stefaniak, Nessa
    Walker, Jennifer
    Murphy, Monica L.
    McKinney, Mishellene
    Liu, Lu
    Edge, Stephen B.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (29)
  • [28] Clustering clinical trials with similar eligibility criteria features
    Hao, Tianyong
    Rusanov, Alexander
    Boland, Mary Regina
    Weng, Chunhua
    JOURNAL OF BIOMEDICAL INFORMATICS, 2014, 52 : 112 - 120
  • [29] Time for More Inclusive Cancer Trials
    Dirix, Piet
    Wyld, Lynda
    Paluch-Shimon, Shani
    Poortmans, Philip
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (10): : 1431 - 1434
  • [30] Optimising eligibility criteria for lung cancer screening
    Crosbie, Philip A. J.
    Callister, Matthew E. J.
    LANCET RESPIRATORY MEDICINE, 2023, 11 (08): : 665 - 666